BIRC5 and breast cancer: Subsequent studies reported that transfection with dominant-negative mutants of survivin led to suppression of growth and increased apoptosis in gastric cancer cell lines [125], and to suppression of tumor growth in breast cancer [126] and thymic lymphoma [102] animal models.